Advertisement

Pediatric Nephrology

, Volume 22, Issue 12, pp 2067–2072 | Cite as

Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura

  • Keith K. Lau
  • Robert J. Wyatt
  • Zina Moldoveanu
  • Milan Tomana
  • Bruce A. Julian
  • Ronald J. Hogg
  • Jeannette Y. Lee
  • Wen-Qiang Huang
  • Jiri Mestecky
  • Jan NovakEmail author
Original Article

Abstract

IgA nephropathy and Henoch-Schönlein purpura nephritis (HSPN) are related diseases characterized by deposits of IgA1-containing immune complexes in the renal mesangium. Adult patients with IgA nephropathy have aberrantly glycosylated IgA1 (galactose-deficient O-linked glycans) in the circulation and renal deposits. However, IgA1 glycosylation has not been studied in pediatric patients with IgA nephropathy. Using our quantitative lectin enzyme-linked immunosorbent assay (ELISA) test, we measured serum levels of galactose-deficient IgA1 of children with IgA nephropathy and HSPN and controls. Children with IgA nephropathy and HSPN had serum levels higher than those of healthy children or renal-disease controls with C1q nephropathy. Furthermore, lectin ELISA identified patients with HSPN whose clinical course mimicked that of IgA nephropathy. In summary, pediatric patients with IgA nephropathy and HSPN have an aberrancy in the glycosylation in IgA1 O-linked glycans that is similar to that in adults with IgA nephropathy.

Keywords

IgA nephropathy Henoch-Schönlein purpura Aberrant glycosylation IgA1 Lectin ELISA 

Notes

Acknowledgements

This work was supported by National Institutes of Health grants DK57750, DK61525, DK71802, DK78244, and DK64400, by grants to the General Clinical Research Centers of the University of Tennessee Health Sciences Center M01, RR00211, and the University of Alabama at Birmingham M01, RR00032, and by a generous gift to the University of Tennessee Pediatric Nephrology Research Support Fund by Anna and Donald Waite. The authors express their appreciation to Dr. Kimberly Fisher and Sandra Grimes (University of Tennessee) for collecting serum samples and clinical data and to Rose Kulhavy (University of Alabama at Birmingham) for providing the IgA1 myeloma protein. The authors appreciate the technical assistance of Rhubell Brown, Stacy Hall, Candace Kirksey, and Claretha Nichols in the processing of the serum samples.

References

  1. 1.
    D’Amico G (1987) The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64:709–727PubMedGoogle Scholar
  2. 2.
    Delos Santos NM, Wyatt RJ (2004) Pediatric IgA nephropathies: Clinical aspects and therapeutic approaches. Semin Nephrol 24:269–286CrossRefGoogle Scholar
  3. 3.
    Saulsbury FT (2001) Henoch-Schönlein purpura. Curr Opin Rheumatol 13:35–40PubMedCrossRefGoogle Scholar
  4. 4.
    Levy M, Broyer M, Arsan A, Levy-Bentolila D, Habib R (1976) Anaphylactoid purpura nephritis in childhood: Natural history and immunopathology. Adv Nephrol 6:183–228Google Scholar
  5. 5.
    Evans DJ, Gwynn-Williams D, Peters DK, Sissons JG, Boulton-Jones JM, Ogg CS, Cameron JS, Hoffbrand BI (1973) Glomerular deposition of properdin in Henoch-Schönlein purpura syndrome and idiopathic focal glomerulonephritis. Br Med J 11:326–328CrossRefGoogle Scholar
  6. 6.
    Meadow SR, Scott DG (1985) Berger disease: Henoch-Schönlein syndrome without the rash. J Pediatr 106:27–32PubMedCrossRefGoogle Scholar
  7. 7.
    Levy M (1989) Familial cases of Berger’s disease and anaphylactoid purpura: more frequent than previously thought. Am J Med 87:246–248PubMedCrossRefGoogle Scholar
  8. 8.
    Nakamoto Y, Asano Y, Dohi K, Fujioka M, Iida H, Kida H, Kibe Y, Hattori N, Takeuchi J (1978) Primary IgA glomerulonephritis and Schonlein-Henoch purpura nephritis: clinicopathological and immunohistological characteristics. Q J Med 47:495–516PubMedGoogle Scholar
  9. 9.
    Waldo FB (1988) Is Henoch-Schönlein purpura the systemic form of IgA nephropathy? Am J Kidney Dis 12:373–377PubMedGoogle Scholar
  10. 10.
    Andre PM, Le Pogamp P, Chevet D (1990) Impairment of jacalin binding to serum IgA in IgA nephropathy. J Clin Lab Anal 4:115–119PubMedCrossRefGoogle Scholar
  11. 11.
    Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S (1993) Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 104:172–182PubMedGoogle Scholar
  12. 12.
    Allen AC, Harper SJ, Feehally J (1995) Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100:470–474PubMedCrossRefGoogle Scholar
  13. 13.
    Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J (1997) Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52:509–516PubMedCrossRefGoogle Scholar
  14. 14.
    Allen AC, Willis FR, Beattie TJ, Feehally J (1998) Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 13:930–934PubMedCrossRefGoogle Scholar
  15. 15.
    Coppo R, Basolo B, Martina G, Rollino C, De Marchi M, Giacchino F, Mazzucco G, Messina M, Piccoli G (1982) Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schönlein nephritis. Correlation with clinical and histologic signs of activity. Clin Nephrol 18:230–239PubMedGoogle Scholar
  16. 16.
    Amore A, Cirina P, Conti G, Brusa P, Peruzzi L, Coppo R (2001) Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 12:1862–1871PubMedGoogle Scholar
  17. 17.
    Coppo R, Amore A (2004) Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65:1544–1547PubMedCrossRefGoogle Scholar
  18. 18.
    Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J (2005) IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67:504–513PubMedCrossRefGoogle Scholar
  19. 19.
    Hogg R, Tomana M, Gray J, Mestecky J (1997) Deficient IgA1 galactosylation in children with idiopatic IgA nephropathy (IgAN) and Henoch-Schönlein nephritis (HSPN). J Am Soc Nephrol 8:88AGoogle Scholar
  20. 20.
    Moore JS, Kulhavy R, Tomana M, Moldoveanu Z, Suzuki H, Brown R, Hall S, Kilian M, Poulsen K, Mestecky J, Julian BA, Novak J (2007) Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins. Mol Immunol 44:2598–2604PubMedCrossRefGoogle Scholar
  21. 21.
    Moldoveanu Z, Wyatt RJ, Lee J, Tomana M, Julian BA, Mestecky J, Huang W-Q, Anreddy SR, Hastings MC, Lau KK, Cook WJ, Novak J (2007) Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71:134–138CrossRefGoogle Scholar
  22. 22.
    Schwartz GJ, Haycock GB, Edelman CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and serum creatinine. Pediatrics 58:522–526Google Scholar
  23. 23.
    Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104:73–81PubMedGoogle Scholar
  24. 24.
    Yoshikawa N, Ito H, Nakamura H (1992) Prognostic indicators in childhood IgA nephropathy. Nephron 60:60–67PubMedCrossRefGoogle Scholar
  25. 25.
    Ariceta G, Gallego N, Lopez-Fernandez Y, Vallo A, Quintella MJ, Rodriquez Soriano J (2001) Long-term prognosis of childhood IgA nephropathy in adult life. Med Clin 116:361–364Google Scholar
  26. 26.
    Delos Santos NM, Ault BH, Gharavi AG, Kritchevsky SB, Quasney MW, Jackson EC, Fisher KA, Woodford SY, Mitchell BL, Gaber LW, Arheart KL, Wyatt RJ (2002) Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy. Pediatr Nephrol 17:496–502PubMedCrossRefGoogle Scholar
  27. 27.
    Yoshikawa N, Iijima K, Matsuyama S, Suzuki J, Kameda A, Okada S, Nakamura H (1990) Repeat renal biopsy in children with IgA nephropathy. Clin Nephrol 33:160–167PubMedGoogle Scholar
  28. 28.
    Xu LX, Zhao MH (2005) Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int 68:167–172PubMedCrossRefGoogle Scholar
  29. 29.
    Lau KK, Wyatt RJ, Gaber LW (2005) Purpura followed by proteinuria in a 7-year-old girl. Am J Kidney Dis 46:1140–1144PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2007

Authors and Affiliations

  • Keith K. Lau
    • 1
  • Robert J. Wyatt
    • 2
  • Zina Moldoveanu
    • 3
  • Milan Tomana
    • 4
  • Bruce A. Julian
    • 3
    • 4
  • Ronald J. Hogg
    • 5
  • Jeannette Y. Lee
    • 4
  • Wen-Qiang Huang
    • 3
  • Jiri Mestecky
    • 3
    • 4
  • Jan Novak
    • 3
    • 6
    Email author
  1. 1.Department of PediatricsUniversity of California at DavisDavisUSA
  2. 2.Department of PediatricsUniversity of Tennessee Health Sciences Center and Children’s Foundation Research CenterMemphisUSA
  3. 3.Department of MicrobiologyUniversity of Alabama at BirminghamBirminghamUSA
  4. 4.Department of MedicineUniversity of Alabama at BirminghamBirminghamUSA
  5. 5.St. Joseph’s Hospital and Medical CenterPhoenixUSA
  6. 6.Department of MicrobiologyUniversity of Alabama at BirminghamBirminghamUSA

Personalised recommendations